This kit is intended for the in vitro quantitative detection of Serum Amyloid A (SAA) concentration in human serum, plasma and whole blood samples. It provides automated and objective results within 10 minutes by immunofluorescence assay.
– Useful for auxiliary diagnosis of patients’ inflammation and
other related diseases.
– Quantitative and non-subjective results by printer
– Simplified device usage
– Accurate, fast, and safe results
– Suitable for mass-screening
– Test Cassette
– Sample Diluent
– Pipette Tip
– ID Chip
– Instruction for Use
Intended use | Detection of SARS-CoV-2 antigen |
---|---|
Storage | 2-30℃ / 35.6-86℉ |
Specimen type | Nasal swab |
Time to result | 15-30 minutes |
Shelf life | 24 months |
Sensitivity | 93.1% |
Specificity | 100.0% |
.embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .embed-container iframe, .embed-container object, .embed-container embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }
Ref. No. | Target | Specimen | Kit Size | Certification |
---|---|---|---|---|
VMPO29 |
Serum Amyloid A Determination |
S/P/WB |
25 T |
|
S: Serum, P: Plasma, WB: Whole Blood